Apyx Medical Corp at JMP Securities Life Sciences Conference Transcript
Thank you for coming here today, Charlie, and we're kicking off day two. This is Charlie Goodwin from Apyx Medical, it's a company we've covered for a long time now since the prior management was there.
Questions & Answers
So I guess of late, you've had some good news and I think we start off with that so -- you got the first of your 510(k)s cleared on May 26. And that's what led us to reinstate a market outperform and with an $11 price target. And I think we certainly had thoughts, but I'd love to get yours as well -- sentiment, safety profile, and the specific label you got, just talk about what that means to you and how you think that might impact some of your other submissions?
Yes. No. Thanks, Dave, and thanks for having us here. It was obviously a huge milestone for the company. It's something that we've been working on, quite frankly, for many years. One of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |